Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B - Takeaways - MDSpire

Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B

  • By

  • Xinrong Zhang

  • Vy H Nguyen

  • Leslie Yeeman Kam

  • Scott D Barnett

  • Linda Henry

  • Ramsey Cheung

  • Mindie H Nguyen

  • December 12, 2024

  • 0 min

Share

  • 1

    The study analyzed metabolic risk factors and statin use in relation to liver and nonliver outcomes in chronic hepatitis B patients.

  • 2

    Patients with diabetes mellitus and other metabolic risk factors had significantly higher risks for liver and nonliver complications.

  • 3

    Statin use was associated with reduced liver outcomes among patients with lower metabolic burden but not among those with higher burden.

  • 4

    Chronic hepatitis B is linked to increased risks of liver cirrhosis and hepatocellular carcinoma, exacerbated by metabolic syndrome.

  • 5

    The research highlights the need for monitoring metabolic burden in chronic hepatitis B patients to improve clinical outcomes.

Original Source(s)

Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B

  • by Xinrong Zhang, Vy H Nguyen, Leslie Yeeman Kam, Scott D Barnett, Linda Henry, Ramsey Cheung, Mindie H Nguyen

  • December 12, 2024

Related Content

EBM BLS: Pitavastatin Reduces Cardiovascular Events in People Living with HIV With Low-to-Moderate Cardiovascular Risk

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort